Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

LY315920(Varespladib) iglinide Calcium FAK signaling in human cancer

SKU: 44693778847

4.1
PLN121.00 PLN167.00

Pay in 4 interest-free payments of $30.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 14 - Oct 19

Live Spec

LY315920(Varespladib) iglinide Calcium FAK signaling in human cancerVarespladib, aslo known as LY315920, is a secreted phospholipase A2 (sPLA2) inhibitor (IC50 = 50 750 nM for a range of sPLA2 isoforms). Varespladib reduces atherosclerosis and aneurysm formation in ApoE mice and in guinea pigs. Varespladib significantly reduces the post ACS inflammatory response in those with and without diabetes. Varespladib may be potentially useful for treatment of coronary artery disease. Product information CAS Number: 172732 68

Store: yutopean.com · Domain: yutopean.com

Description

FAK signaling in human cancer as a target for therapeutics

Flanagan ME

However in the intact RBL-I cell prostaglandin synthetase (IC50 of 3

Tacrolimus hydrate

Sakamoto S

LY315920(Varespladib) iglinide Calcium FAK signaling in human cancerVarespladib, aslo known as LY315920, is a secreted phospholipase A2 (sPLA2) inhibitor (IC50 = 50 750 nM for a range of sPLA2 isoforms). Varespladib reduces atherosclerosis and aneurysm formation in ApoE mice and in guinea pigs. Varespladib significantly reduces the post ACS inflammatory response in those with and without diabetes. Varespladib may be potentially useful for treatment of coronary artery disease. Product information CAS Number: 172732 68

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products